AZN
AstraZeneca PLC$177.89
LiveJun 17, 2026
Market cap
$275.88B
52w range
137.22 – 212.71
P / E
—
EPS
—
Volume
1.73M
Revenue · FY
—
Explain this page
Arphra AIPlain-English read on AstraZeneca PLC’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $186.67 (+4.94%)
Candlestick · 1Y
Open in chart workstation →AZN
177.27+25.75%H 212.71L 134.90MA50 189.05MA200 181.62Avg vol 2.5M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46% | -2.54% | -2.03% | -7.01% | -3.71% | +1.36% | +26.19% | +19.19% | +52.56% | +222.50% | +1664.78% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$181.40
1 sh
Bid
$177.86
101 sh
Ask
$184.96
1 sh
Spread
$7.100
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Utilities+3.33%
- Financial Services+0.02%
- Industrials-0.12%
- Healthcare-0.72%
- Energy-0.94%
- Technology-0.95%
- Consumer Defensive-1.52%
- Basic Materials-1.60%
- Consumer Cyclical-1.74%
- Communication Services-1.79%
- Real Estate-2.19%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-0.39%
- Auto - Dealerships-6.22%
- Trucking-5.25%
- Renewable Utilities+5.11%
- Oil & Gas Energy-4.86%
- Consulting Services-4.82%
- Financial - Mortgages-4.15%
- REIT - Office-3.71%
- Software - Application-3.50%
- Medical - Healthcare Information Services-3.48%
- Grocery Stores-3.45%
- Discount Stores-3.44%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$186.67
+4.94% upside
Low
$158.00
Median
$185.00
High
$216.00
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- FDA Accepts AstraZeneca's Filing for Expanded Use of Ultomiriszacks.com·Jun 16, 2026
- AstraZeneca Stock Down 7% in 3 Months: Should You Buy, Sell or Hold?zacks.com·Jun 16, 2026
- AstraZeneca's Truqap Wins FDA Nod for Prostate Cancer Indicationzacks.com·Jun 15, 2026
- Astrazeneca (AZN) Outperforms Broader Market: What You Need to Knowzacks.com·Jun 11, 2026
- AstraZeneca's GLP-1 Pill Heads To Late-Stage Trialsbenzinga.com·Jun 09, 2026
- AstraZeneca's obesity drug shows promise as analysts see upside beyond consensusinvezz.com·Jun 09, 2026
- AstraZeneca obesity pill helps patients lose 10.5% of body weight in trialreuters.com·Jun 08, 2026
- AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of successcnbc.com·Jun 05, 2026
Peers
No peer list available for AZN.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|